Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00335491 · ClinicalTrials.gov registry record · NA
Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors
A NA study, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 49
- Enrollment target
NCT00335491: Completed NA study, sponsored by University of Utah.
NCT00335491 is a NA study that has completed, run by University of Utah. The registered enrollment target is 49 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00335491, a NA study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 49 participants
- Enrollment target
Study Summary
RATIONALE: Exercise may help improve mobility and relieve fatigue and/or weakness in cancer survivors. It is not yet known whether exercise is more effective than standard therapy in improving mobility and reducing fatigue and/or weakness in older cancer survivors. PURPOSE: This randomized clinical trial is studying exercise to see how well it works compared to standard therapy in improving mobility and reducing fatigue and/or weakness in older cancer survivors.
Primary Outcome
To explore the participant's perception and pattern of change in fatigue, weakness, physical activity level and functional status
Interventions
- BEHAVIORAL exercise intervention
- PROCEDURE fatigue assessment and management
- PROCEDURE complementary or alternative medicine procedure
- PROCEDURE physical therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2006-03 |
| Est. Completion | 2010-03 |
| Phase | NA |
What the finished NCT00335491 record still lists
NCT00335491 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 49 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which exercise intervention is the first listed.
NCT00335491 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00335491 about?
NCT00335491 is a clinical study titled "Exercise in Improving Mobility and Reducing Fatigue and/or Weakness in Older Cancer Survivors". RATIONALE: Exercise may help improve mobility and relieve fatigue and/or weakness in cancer survivors. It is not yet known whether exercise is more effective than standard therapy in improving mobility and reducing fatigue and/or weakness in older cancer survivors. PURPOSE: This randomized clinical...
What is the current status of trial NCT00335491?
This trial is currently completed. It is a NA study. The enrollment target is 49 participants. The study started on 2006-03. Estimated completion is 2010-03.
What interventions are being tested in trial NCT00335491?
The interventions under investigation include: exercise intervention (BEHAVIORAL), fatigue assessment and management (PROCEDURE), complementary or alternative medicine procedure (PROCEDURE), physical therapy (PROCEDURE).
Who is sponsoring clinical trial NCT00335491?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00335491's enrollment target sits among peer trials
49 1379th of 2000 higher than 620 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia